Nitric oxide: A promising methodological approach in airway diseases

International Archives of Allergy and Immunology

Volumn 156, Issue 4, 2011, Pages 352-361

  Sahin, G ^a,b   Klimek, L ^a   Mullol, J ^d   Hormann K ^b   Walther, L E ^c   Pfaar, O ^a,b  

^a Centre for Rhinology and Allergology   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c ORL Practice ^*  (Germany)

^d INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

Author keywords

Airway inflammation; Allergic rhinitis; Asthma; Chronic rhinosinusitis; Cystic fibrosis; Nasal polyps; Nitric oxide; Primary ciliary dyskinesia

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; INDUCIBLE NITRIC OXIDE SYNTHASE; NEURONAL NITRIC OXIDE SYNTHASE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

ALLERGIC RHINITIS; CILIARY DYSKINESIA; CYSTIC FIBROSIS; HOST RESISTANCE; HUMAN; NONHUMAN; NOSE; NOSE POLYP; PARANASAL SINUS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RESPIRATORY TRACT DISEASE; REVIEW; RHINOSINUSITIS;

HUMANS; NITRIC OXIDE; RESPIRATORY TRACT DISEASES;

EID: 79961122501     PISSN: 10182438     EISSN: 14230097     Source Type: Journal    
DOI: 10.1159/000324678     Document Type: Review

References (109)

1. Murad F, Mittal CK, Arnold WP, Katsuki S, Kimura H: Guanylate cyclase: activation by azide, nitro compounds, nitric oxide, and hydroxyl radical and inhibition by hemoglobin and myoglobin. Adv Cyclic Nucleotide Res 1978; 9: 145-158.
2. Furchgott RF, Zawadzki JV: The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 1980; 288: 373-376. (Pubitemid 11169009)
3. Ignarro L, Buga G, Wood K, Byrns R, Chaudhuri G: Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc Natl Acad Sci USA 1987; 84: 9265-9269.
4. Palmer RM, Ferrige AG, Moncada S: Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 1987; 327: 524-526. (Pubitemid 17085822)
5. Gustafsson I, Leone A, Persson M, Wiklund N, Moncada S: Endogenous nitric oxide is present in the exhaled air of rabbits, guinea pigs and humans. Biochem Biophys Res Commun 1991; 181:852-857.
6. Alving K, Weitzberg E, Lundberg JM: Increased amount of nitric oxide in exhaled air of asthmatics. Eur Respir J 1993; 6: 1368-1370. (Pubitemid 23329557)
7. Moncada S, Higgs A: The L-arginine-nitric oxide pathway. N Engl J Med 1993; 329: 2002-2012. (Pubitemid 24015045)
8. Nathan C, Xie QW: Nitric oxide synthases: roles, tolls, and controls. Cell 1994; 78: 915-918. (Pubitemid 24292319)
9. Kelm M: Nitric oxide metabolism and breakdown. Biochim Biophys Acta 1999; 1411: 273-289. (Pubitemid 29221955)
10. Nathan C: Nitric oxide as a secretory product of mammalian cells. FASEB J 1992; 6: 3051-3064.
11. Djupesland P, Chatkin J, Qian W: Nitric oxide in the nasal airway: a new dimension in otorhinolaryngology. Am J Otolaryngol 2001; 22: 19-32. (Pubitemid 32156412)
12. Förstermann U, Closs E: Nitric oxide synthase isoenzymes: characterisation, purification, molecular cloning, and functions. Hypertension 1994; 23: 1121-1131. (Pubitemid 24180877)
13. Nathan C: Inducible nitric oxide synthase: what difference does it make? J Clin Invest 1997; 100: 2417-2423. (Pubitemid 27514879)
14. Nathan C, Xie QW: Regulation of biosynthesis of nitric oxide. J Biol Chem 1994; 269: 13725-13728. (Pubitemid 24191108)
15. Hibbs JB Jr: Infection and nitric oxide. J Infect Dis 2002; 18(suppl 1):S9-S17. (Pubitemid 34142824)
16. Rimele TJ, Sturm RJ, Adams LM, Henry DE, Heaslip RJ, Weichman BM, Grimes D: Interaction of neutrophils with vascular smooth muscle: identification of a neutrophil-derived relaxing factor. J Pharmacol Exp Ther 1988; 245: 102-111.
17. Jorens PG, Van Overveld FJ, Bult H, Vermeire PA, Herman AG: L-Arginine-dependent production of nitrogen oxides by rat pulmonary macrophages. Eur J Pharmacol 1991; 200: 205-209.
18. Lundberg JO, Weitzberg E, Rinder J, Rudehill A, Jansson O, Wiklund NP, et al: Calcium-independent and steroid-resistant nitric oxide synthase activity in human paranasal sinus mucosa. Eur Respir J 1996; 9: 1344-1347. (Pubitemid 26233772)
19. Maniscalco M, Sofia M, Pelaia G: Nitric oxide in upper airways inflammatory diseases. Inflamm Res 2007; 56: 58-69. (Pubitemid 46412015)
20. Kharitonov S, Alving K, Barnes PJ: Exhaled and nasal nitric oxide measurements: recommendations. The European Respiratory Society Task Force. Eur Respir J 1997; 10: 1683-1693. (Pubitemid 27311092)
21. Lundberg J, Rinder J, Weitzberg E, Lundberg JM, Alving K: Nasally exhaled nitric oxide in humans originates mainly in the paranasal sinuses. Acta Physiol Scand 1994; 152: 431-432. (Pubitemid 24378033)
22. Lundberg JO, Farkas-Szallasi T, Weitzberg E, Rinder J, Lidholm J, Anggaard A, Hökfelt T, Lundberg JM, Alving K: High nitric oxide production in human paranasal sinuses. Nat Med 1995; 1: 370-373.
23. Kimberly B, Nejadnik B, Giraud GD: Nasal contribution to exhaled nitric oxide at rest and during breathholding in humans. Am J Resp Crit Care Med 1996; 153: 829-836. (Pubitemid 26051368)
24. Dillon WC, Hampl V, Shultz PJ, Rubins JB, Archer SL: Origins of breath nitric oxide in humans. Chest 1996; 110: 930-938. (Pubitemid 26347606)
25. Lundberg J, Weitzberg E, Nordvall S: Primarily nasal origin of exhaled nitric oxide and absence in Katagener's syndrome. Eur Resp J 1994; 7: 1501-1504. (Pubitemid 24268339)
26. Schedin U, Frostell C, Persson MG, Jakobsson J, Andersson G, Gustafsson LE: Contribution from upper and lower airways to exhaled endogenous nitric oxide in humans. Acta Anaesthesiol Scand 1995; 39: 327-332.
27. Kramer MF, Olzowy B, Bihler A, de la Motte D, Nowak D, Jorres RA, Dressel H: Exhaled and nasal nitric oxide in laryngectomized patients. BMC Pulm Med 2010; 10: 4.
28. Lundberg JO, Weitzberg E: Nasal nitric oxide in man. Thorax 1999; 54: 947-952. (Pubitemid 29452805)
29. Haight J, Djupesland P, Qjan W, Chatkin J, Furlott H, Irish H: Does nasal nitric oxide come from the sinuses? Otolaryngol 1999; 28: 197-204. (Pubitemid 29444237)
30. Kawamoto H, Takeno S, Yajin K: Increased expression of inducible nitric oxide synthase in nasal epithelial cells in patients with allergic rhinitis. Laryngoscope 1999; 109: 2015-2020.
31. Kawamoto H, Takumida M, Takeno S, Watanabe H, Fukushima N, Yajin K: Localization of nitric oxide synthase in human nasal mucosa with nasal allergy. Acta Otolaryngol Suppl 1998; 539: 65-70. (Pubitemid 29111467)
32. Giannessi F, Fattori B, Ursino F, Giambelluca MA, Soldani P, Scavuzzo MC, Ruffoli R: Ultrastructural and ultracytochemical study of the human nasal respiratory epithelium in vasomotor rhinitis. Acta Otolaryngol 2003; 123: 943-949. (Pubitemid 37346553)
33. Kirihene RK, Rees G, Wormald PJ: The influence of the size of the maxillary sinus ostium on the nasal and sinus nitric oxide levels. Am J Rhinol 2002; 16: 261-264. (Pubitemid 35314856)
34. Croen KD: Evidence for antiviral effect of nitric oxide: inhibition of herpes simplex virus type 1 replication. J Clin Invest 1993; 91: 2446-2452. (Pubitemid 23182495)
35. Mancinelli RL, McKay CP: Effects of nitric oxide and nitrogen dioxide on bacterial growth. Appl Environ Microbiol 1983; 46: 198-202. (Pubitemid 13045860)
36. Jain B, Rubinstein I, Robbins RA, Leise KL, Sisson JH: Modulation of airway epithelial cell ciliary beat frequency by nitric oxide. Biochem Biophys Res Commun 1993; 191: 83-88. (Pubitemid 23222606)
37. Alberty J, Stoll W, Rudack C: The effect of endogenous nitric oxide on mechanical ciliostimulation of human nasal mucosa. Clin Exp Allergy 2006; 36: 1254-1259. (Pubitemid 44498232)
38. Runer T, Lindberg S: Effects of nitric oxide on blood flow and mucociliary activity in the human nose. Ann Otol Rhinol Laryngol 1998; 107: 40-46. (Pubitemid 28041886)
39. Lundberg Jo, Lundberg JM, Settergreen G, Alving K, Weitzberg E: Nitric oxide, produced in the upper airways, may act in an 'aerocrine' fashion to enhance pulmonary oxygen uptake in humans. Acta Physiol Scand 1995; 155: 467-468. (Pubitemid 26017515)
40. Lundberg JO, Settergren G, Gelinder S, Lundberg JM, Alving K, Weitzberg E: Inhalation of nasally derived nitric oxide modulates pulmonary function in humans. Acta Physiol Scand 1996; 158: 343-347. (Pubitemid 26426964)
41. Gerlach H, Rossaint R, Pappert D, Falke KJ: Time-course and dose-response of nitric oxide inhalation for systemic oxygenation and pulmonary hypertension in patients with adult respiratory distress syndrome. Eur J Clin Invest 1993; 23: 499-502. (Pubitemid 23243942)
42. Puybasset L, Rouby JJ, Mourgeon E, Stewart TE, Cluzel P, Arthaud M, Poète P, Bodin L, Korinek AM, Viars P: Inhaled nitric oxide in acute respiratory failure: dose-response curves. Intensive Care Med 1994; 20: 319-327. (Pubitemid 24190957)
43. Busch T, Kuhlen R, Knorr M, Kelly K, Lewandowski K, Rossaint R, Falke KJ, Gerlach H: Nasal, pulmonary and autoinhaled nitric oxide at rest and during moderate exercise. Intensive Care Med 2000; 26: 391-399. (Pubitemid 30301519)
44. Gerlach H, Rossaint R, Pappert D, Knorr M, Falke KJ: Autoinhalation of nitric oxide after endogenous synthesis in nasopharynx. Lancet 1994; 343: 518-519. (Pubitemid 24062289)
45. Tornberg DC, Marteus H, Schedin U, Alving K, Lundberg JO, Weitzberg E: Nasal and oral contribution to inhaled and exhaled nitric oxide: a study in tracheotomized patients. Eur Respir J 2002; 19: 859-864. (Pubitemid 34567899)
46. Frostell C, Fratacci MD, Wain JC, Jones R, Zapol WM: Inhaled nitric oxide: a selective pulmonary vasodilator reversing hypoxic pulmonary vasoconstriction. Circulation 1991; 83: 2038-2047.
47. Roberts JD Jr, Fineman JR, Morin FC 3rd, Shaul PW, Rimar S, Schreiber MD, Polin RA, Zwass MS, Zayek MM, Gross I, Heymann MA, Zapol WM: Inhaled nitric oxide and persistent pulmonary hypertension of the newborn. The Inhaled Nitric Oxide Study Group. N Engl J Med 1997; 336: 605-610. (Pubitemid 27093405)
48. Alving K, Janson C, Nordvall L: Performance of a new hand-held device for exhaled nitric oxide measurement in adults and children. Respir Res 2006; 7: 67.
49. Menzies D, Nair A, Lipworth BJ: Portable exhaled nitric oxide measurement: comparison with the 'gold standard' technique. Chest 2007; 131: 410-414. (Pubitemid 46280400)
50. Khalili B, Boggs PB, Bahna SL: Reliability of a new hand-held device for the measurement of exhaled nitric oxide. Allergy 2007; 62: 1171-1174. (Pubitemid 47374024)
51. Olin A, Bake B: Fraction of exhaled nitric oxide at 50 ml/s: reference values for adult lifelong never-smokers. Chest 2007; 131: 1852-1856. (Pubitemid 46981645)
52. Struben VM, Wieringa MH, Mantingh CJ, Bommeljé C, Don M, Feenstra L, de Jongste JC: Nasal NO: normal values in children age 6 through to 17 years. Eur Respir J 2005; 26: 453-457. (Pubitemid 41264208)
53. Daya H, Qian W, McClean P, Haight J, Zamel N, Papsin BC, Forte V: Nasal nitric oxide in children: a novel measurement technique and normal values. Laryngoscope 2002; 112: 1831-1835.
54. Cobos Barroso N, Reverté Bover C, Gartner S, Liñán Cortés S, Quintó Domech L: Exhaled and nasal nitric oxide in normal and asthmatic children (in Spanish). An Esp Pediatr 1998; 49: 241-247. (Pubitemid 28498404)
55. Balfour-Lynn IM, Laverty A, Dinwiddie R: Reduced upper airway nitric oxide in cystic fibrosis. Arch Dis Child 1996; 75: 319-322. (Pubitemid 26354603)
56. Kharitonov SA, Chung KF, Evans D, O'Connor BJ, Barnes PJ: Increased exhaled nitric oxide in asthma is mainly derived from the lower respiratory tract. Am J Respir Crit Care Med 1996; 153: 1773-1780. (Pubitemid 26187898)
57. Guilemany JM, García-Piñero A, Alobid I, Cardelús S, Centellas S, Bartra J, Valero A, Picado C, Mullol J: Persistent allergic rhinitis has a moderate impact on the sense of smell, depending on both nasal congestion and inflammation. Laryngoscope 2009; 119: 233-238.
58. Arnal J: Nasal nitric oxide is increased in allergic rhinitis. Clin Exp Allergy 1997; 27: 358-362. (Pubitemid 27183357)
59. Henriksen A, Sue-Chu M, Holmen T, Langhammer A, Bjermer L: Exhaled and nasal NO levels in allergic rhinitis: relation to sensitization, pollen season and bronchial hyperresponsiveness. Eur Respir J 1999; 13: 301-306. (Pubitemid 29086824)
60. Kharitonov S: Nasal nitric oxide is increased in patients with asthma and allergic rhinitis and may be modulated by nasal glucocorticoids. Allergy Clin Immunol 1997; 99: 58-64. (Pubitemid 27074898)
61. Martin U, Bryden K, Devoy M, Howarth P: Increased levels of exhaled nitric oxide during nasal and oral breathing in subjects with seasonal rhinitis. J Allergy Clin Immunol 1996; 97: 768-772. (Pubitemid 26089250)
62. Takeno S, Osada R, Furukido K, Chen JH, Yajin K: Increased nitric oxide production in nasal epithelial cells from allergic patients-RT-PCR analysis and direct imaging by a fluorescence indicator: DAF-2 DA. Clin Exp Allergy 2001; 31: 881-888. (Pubitemid 34204260)
63. Sato M, Fukuyama M: Increased nitric oxide in nasal lavage fluid and nitrotyrosine formation in nasal mucosa-indices for severe perennial nasal allergy. Clin Exp Allergy 1998; 28: 597-605. (Pubitemid 28238275)
64. Palm JP, Alving K, Lundberg JO: Characterization of airway nitric oxide in allergic rhinitis: the effect of intranasal administration of L-NAME. Allergy 2003; 58: 885-892. (Pubitemid 37046687)
65. Maniscalco M, Sofia M, Carratu L, Higenbottam T: Effect of nitric oxide inhibition on nasal airway resistance after nasal allergen challenge in allergic rhinitis. Eur J Clin Invest 2001; 31: 462-466. (Pubitemid 32476966)
66. Valero A, Serrano C, Valera JL, Barberá A, Torrego A, Mullol J, Picado C: Nasal and bronchial response to exercise in patients with asthma and rhinitis: the role of nitric oxide. Allergy 2005; 60: 1126-1131. (Pubitemid 41153138)
67. Meurs H, Hamer MA, Pethe S, Vadon-Le Goff S, Boucher JL, Zaagsma J: Modulation of cholinergic airway reactivity and nitric oxide production by endogenous arginase activity. Br J Pharmacol 2000; 130: 1793-1798. (Pubitemid 30655789)
68. Chicoine LG, Paffett ML, Young TL, Nelin LD: Arginase inhibition increases nitric oxide production in bovine pulmonary arterial endothelial cells. Am J Physiol Lung Cell Mol Physiol 2004; 287:L60-L68. (Pubitemid 38787651)
69. Maarsingh H, Leusink J, Bos IS, Zaagsma J, Meurs H: Arginase strongly impairs neuronal nitric oxide-mediated airway smooth muscle relaxation in allergic asthma. Respir Res 2006; 7: 6.
70. Colantonio D, Brouillette L, Parikh A, Scadding GK: Paradoxical low nasal nitric oxide in nasal polyposis. Clin Exp Allergy 2002; 32: 698-701. (Pubitemid 34534014)
71. Guilemany J, Angrill J, Alobid I: United airways again: high prevalence of rhinosinusitis and nasal polyps in bronchiectasis. Allergy 2009; 64: 790-797.
72. Gilain L, Bedu M, Jouaville L, Guichard C, Advenier D, Mom T, Laurent S, Caillaud D: Analysis of nasal and exhaled nitric oxide concentration in nasal polyposis (in French). Ann Otolaryngol Chir Cervicofac 2002; 119: 234-242.
73. Cekin E, Ipcioglu OM, Erkul BE, Kapucu B, Ozcan O, Cincik H, Gungor A: The association of oxidative stress and nasal polyposis. J Int Med Res 2009; 37: 325-330.
74. Prieto L, Seijas T, Gutierrez V, Uixera S, Bruno L, Lopez R: Exhaled nitric oxide levels and airway responsiveness to adenosine 5-monophosphate in subjects with nasal polyposis. Int Arch Allergy Immunol 2004; 134: 303-309.
75. Ragab SM, Lund VJ, Saleh HA, Scadding G: Nasal nitric oxide in objective evaluation of chronic rhinosinusitis therapy. Allergy 2006; 61: 717-724. (Pubitemid 43801406)
76. Arnal J, Flores P, Rami J, Murris-Espin M, Bremont F, Pasto I: Nasal nitric oxide concentration in paranasal sinus inflammatory diseases. Eur Respir J 1999; 13: 307-312. (Pubitemid 29086825)
77. Delclaux C, Malinvaud D, Chevalier-Bidaud B, Callens E, Mahut B, Bonfils P: Nitric oxide evaluation in upper and lower respiratory tracts in nasal polyposis. Clin Exp Allergy 2008; 38: 1140-1147.
78. Lindberg S, Cervin A, Runer T: Nitric oxide (NO) production in the upper airways is decreased in chronic sinusitis. Acta Otolaryngol 1997; 117: 113-117. (Pubitemid 27077016)
79. Deja M, Busch T, Bachmann S, Riskowski K, Campean V, Wiedmann B, Schwabe M, Hell B, Pfeilschifter J, Falke KJ, Lewandowski K: Reduced nitric oxide in sinus epithelium of patients with radiologic maxillary sinusitis and sepsis. Am J Respir Crit Care Med 2003; 168: 281-286. (Pubitemid 36969878)
80. Baraldi E, Azzolin NM, Biban P, Zacchello F: Effect of antibiotic therapy on nasal nitric oxide concentration in children with acute sinusitis. Am J Respir Crit Care Med 1997; 155: 1680-1683. (Pubitemid 27216677)
81. Degano B, Genestal M, Serrano E, Rami J, Arnal JF: Effect of treatment on maxillary sinus and nasal nitric oxide concentrations in patients with nosocomial maxillary sinusitis. Chest 2005; 128: 1699-1705. (Pubitemid 41324466)
82. Min Y, Lee C, Rhee C: Increased expression of IL-4, IL-5, IFN-gamma, IL-6, IL-8 and TGF-beta mRNAs in maxillary mucosa of patients with chronic sinusitis. Am J Rhinol 1999; 13: 339-343.
83. Zamora R, Vodovotz Y, Billiar TR: Inducible nitric oxide synthase and inflammatory diseases. Mol Med 2000; 6: 347-373.
84. Lundberg JO, Maniscalco M, Sofia M, Lundblad L, Weitzberg E: Humming, nitric oxide, and paranasal sinus obstruction. JAMA 2003; 289: 302-303. (Pubitemid 36083981)
85. Naraghi M, Deroee AF, Ebrahimkhani M, Kiani S, Dehpour A: Nitric oxide: a new concept in chronic sinusitis pathogenesis. Am J Otolaryngol 2007; 28: 334-337. (Pubitemid 47371169)
86. Deroe A, Naraghi M, Sontou AF, Ebrahimkhani MR, Dehpour AR: Nitric oxide metabolites as biomarkers for follow-up after chronic rhinosinusitis surgery. Am J Rhinol Allergy 2009; 23: 159-161.
87. Bush A: Primary ciliary dyskinesia. Acta Otorhinolaryngol Belg 2000; 54: 317-324.
88. Grasemann H, Gartig S, Wiesemann H: Effect of L-arginine infusion on airway NO in cystic fibrosis and primary ciliary dyskinesia syndrome. Eur Respir J 1999; 13: 114-118. (Pubitemid 29079230)
89. Karadag B, James AJ, Gultekin E, Wilson NM, Bush A: Nasal and lower airway level of nitric oxide in children with primary ciliary dyskinesia. Eur Respir J 1999; 13: 1402-1405. (Pubitemid 29357160)
90. Wodehouse T: Nasal nitric oxide measurements for the screening of primary ciliary dyskinesia. Eur Respir J 2003; 21: 43-47. (Pubitemid 36150299)
91. Horvath I, Loukides S, Wodehouse T, Csiszer E, Cole PJ, Kharitonov SA, Barnes PJ: Comparison of exhaled and nasal nitric oxide and exhaled carbon monoxide levels in bronchiectatic patients with and without primary ciliary dyskinesia. Thorax 2003; 58: 68-72. (Pubitemid 36135362)
92. Csoma Z, Bush A, Wilson NM: Nitric oxide metabolites are not reduced in exhaled breath condensate of patients with primary ciliary dyskinesia. Chest 2003; 124: 633-638. (Pubitemid 37000144)
93. Narang I, Ersu R, Wilson NM, Bush A: Nitric oxide in chronic airway inflammation in children: diagnostic use and pathophysiological significance. Thorax 2002; 57: 586-589. (Pubitemid 34761759)
94. Noone PG, Leigh MW, Sannuti A, Minnix SL, Carson JL, Hazucha M, Zariwala MA, Knowles MR: Primary ciliary dyskinesia: diagnostic and phenotypic features. Am J Respir Crit Care Med 2004; 169: 459-467. (Pubitemid 38187117)
95. Corbelli R, Bringolf-Isler B, Amacher A, Sasse B, Spycher M, Hammer J: Nasal nitric oxide measurements to screen children for primary ciliary dyskinesia. Chest 2004; 126: 1054-1059. (Pubitemid 39391231)
96. Mahut B, Escudier E, de Blic J, Zerah-Lancner F, Coste A, Harf A, Delclaux C: Impairment of nitric oxide output of conducting airways in primary ciliary dyskinesia. Pediatr Pulmonol 2006; 41: 158-163. (Pubitemid 43165445)
97. Scadding G, Scadding K: Update on the use of nitric oxide as a non-invasive measure of airways inflammation. Rhinology 2009; 47: 115-120.
98. Runner T, Cervin A, Lindberg S: Nitric oxide is a regulator of mucociliary activity in the upper respiratory tract. Otolaryngol Head Neck Surg 1998; 119: 278-287. (Pubitemid 28425614)
99. Lindberg S, Cervin A, Runer T: Low levels of nasal nitric oxide (NO) correlate to impaired mucociliary function in the upper airways. Acta Otolaryngol 1997; 117: 728-734. (Pubitemid 27418204)
100. Loukides S, Kharitonov S, Wodehouse T, Cole PJ, Barnes PJ: Effect of arginine on mucociliary function in primary ciliary dyskinesia. Lancet 1998; 352: 371-372. (Pubitemid 28352208)
101. Jeganathan D, Chodhari R, Meeks M, Faeroe O, Smyth D, Nielsen K, Amirav I, Luder AS, Bisgaard H, Gardiner RM, Chung EM, Mitchison HM: Loci for primary ciliary dyskinesia map to chromosome 16p12.1-12.2 and 15q13.1-15.1 in Faroe Islands and Israeli Druze genetic isolates. J Med Genet 2004; 41: 233-240.
102. Escudier E, Duquesnoy P, Papon JF, Amselem S: Ciliary defects and genetics of primary ciliary dyskinesia. Paediatr Respir Rev 2009; 10: 51-54.
103. Buchwalow IB, Minin EA, Muller FU, Lewin G, Samoilova VE, Schmitz W, Wellner M, Hasselblatt M, Punkt K, Müller-Werdan U, Demus U, Slezak J, Koehler G, Boecker W: Nitric oxide synthase in muscular dystrophies: a re-evaluation. Acta Neuropathol 2006; 111: 579-588. (Pubitemid 43785796)
104. Grasemann H, Michler E: Decreased concentrations of exhaled nitric oxide (NO) in patients with cystic fibrosis. Ped Pulmol 1997; 24: 173-177. (Pubitemid 27431226)
105. Zheng S, Xu W, Bose S, Banerjee AK, Haque SJ, Erzurum SC: Impaired nitric oxide synthase-2 signaling pathway in cystic fibrosis airway epithelium. Am J Physiol Lung Cell Mol Physiol 2004; 287:L374-L381. (Pubitemid 38943920)
106. Kelley T, Drumm M: Inducible nitric oxide synthase expression is reduced in cystic fibrosis murine and human airway epithelial cells. J Clin Invest 1998; 102: 1200-1207. (Pubitemid 28436280)
107. Shori DK, Dormer RL, Goodchild MC, McPherson MA: Defective phosphorylation of a calmodulin-binding protein in cystic-fibrosis submandibular glands. Biochem J 1989; 263: 613-616. (Pubitemid 19254170)
108. Grasemann H, Ratjen F: Cystic fibrosis lung disease: the role of nitric oxide. Pediatr Pulmonol 1999; 28: 442-448. (Pubitemid 30017565)
109. Grasemann H, Storm van's Gravesande K, Buscher R, Knauer N, Silverman ES, Palmer LJ, Drazen JM, Ratjen F: Endothelial nitric oxide synthase variants in cystic fibrosis lung disease. Am J Respir Crit Care Med 2003; 167: 390-394. (Pubitemid 36216421)